"We believe these reports are a step forward in meeting an unmet need for a more informed and personalized approach to weight management," said study co-author Noura Abul-Husn, chief medical officer at the 23andMe Research Institute in California, in a press release
Clinical trials demonstrate 15-20% body weight reduction with semaglutide and tirzepatide over 68 weeks
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
Psychiatry 97 , 2840 (2025)
Today, obesity is one of the most acute and common diseases which affect people in different countries
You start at the lowest dose, move to the recommended dose after two weeks, and only increase further if weight loss is insufficient after 12 weeks